Pyxis Oncology, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD for Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Pyxis Oncology, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate for Q1 2024.
  • Pyxis Oncology, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending March 31, 2024 was $8M.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $8M Mar 31, 2024 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.